FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+134.07%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$617M
AUM Growth
+$617M
(+120%)
Cap. Flow
+$33.5M
Cap. Flow
% of AUM
5.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
ALNA
Allena Pharmaceuticals, Inc. Common Stock
ALNA
|
$33.5M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$2.67K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AnaptysBio
ANAB
$569M
| $372M | 60.25% | 3,688,448 | – | – |
|
|
RXDX
2
DELISTED
Ignyta, Inc.
RXDX
| $58M | 9.41% | 2,173,693 +100 | +0% | +$2.67K |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $37.4M | 6.07% | 2,600,014 | – | – |
|
4
Collegium Pharmaceutical
COLL
$1.22B
| $34.8M | 5.65% | 1,887,332 | – | – |
|
|
ALNA
5
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $33.5M | 5.43% | +3,330,373 | New | +$33.5M |
|
|
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $30.3M | 4.91% | 8,112,121 | – | – |
|
|
ALPN
7
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $24.6M | 3.99% | 2,199,011 | – | – |
|
8
Iovance Biotherapeutics
IOVA
$807M
| $17.5M | 2.84% | 2,188,331 | – | – |
|
9
Cidara Therapeutics
CDTX
$1.66B
| $8.92M | 1.45% | 1,312,258 | – | – |
|